Formulations of 6-mercaptopurine
US10525009B2 · kind B2 · utility
0Cited by
33References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 17, 2016 |
| Grant date | Jan 7, 2020 |
| Priority date | — |
| Expiry date | Jun 17, 2036 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB01J2/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides improved formulations of 6-mercaptopurine that exhibit better bioavailability and faster dissolution than previous formulations.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.